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Abstract
Objective: 
            Few data exist about the potential differences in the dyssynchrony status of cardiac 
resynchronization therapy (CRT) candidates stratified by etiology of heart failure, and about the 
evolution of dyssynchrony at long-term follow-up. We provided a description of intra-ventricular 
dyssynchrony at baseline, 6 months and 12 months in ischemic and nonischemic CRT patients.
Methods:
               Tissue Doppler Imaging was performed in 35 CRT candidates (18 ischemic, 17 
nonischemic) at baseline, and at 6-month and 12-month follow-up. A group of 11 healthy 
subjects   was   considered   for   comparison.                                                            
Results:
            At baseline, the standard deviation and the maximum activation delay between any 2 
segments   were   significantly   greater   in   ischemic   (38±33ms,   94±76ms)   and   nonischemic 
(38±24ms, 96±62ms) patients versus controls (9±7ms, 22±15ms) (all p<0.05). The average time 
to activation for posterior and lateral wall was significantly higher in nonischemic patients, while 
the anterior septum activated later in ischemic patients.                                    
               At 6-month follow-up, standard deviation and maximum delay did not vary in 
nonischemic while decreased in ischemic group. All changes persisted at 12 months.     
Conclusions
            No baseline differences were observed between ischemic and nonischemic patients using 
studied indices. At 6- and 12-month follow-up, only ischemic patients presented a significant 
reduction in dyssynchrony values, although in both groups CRT did not lead to a complete 
normalization of LV synchronism.              
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Introduction
               Cardiac Resynchronization Therapy (CRT) has shown to improve symptoms and 
prognosis of patients affected by moderate to severe heart failure (HF) with prolonged QRS 
complex duration1-4. Recently, Sutton et al.5 demonstrated that both left ventricular (LV) reverse 
remodeling and clinical benefits of the therapy are maintained after one year, even if they occur 
to a lesser degree in patients with an ischemic etiology than in patients affected by idiopathic 
dilated   cardiomyopathy.                                                                          
            Several authors assessed left intraventricular dyssynchrony in HF patients to be treated 
with CRT using echocardiography and hypothesized that it could predict the response to the 
therapy6-8, even if more recent data seem to confute this conclusion questioning the feasibility 
and   the   reproducibility   of   these   measures9,10.                                                      
            In these studies, in most cases the population under evaluation was not stratified by the 
etiology of the HF. Yu et al.11 indeed demonstrated that an echocardiographic index of left 
ventricular dyssynchrony is predictive of the response to CRT in two separate groups of 
ischemic   and   nonischemic   patients.                                                                    
            To our knowledge, only Van de Veire et al.12 described dyssynchrony status of HF 
patients stratified by etiology and QRS complex duration, and suggested that the potential 
differences in the area of latest mechanical activation could have practical implications in lead 
positioning   of   a   CRT   system.                                                                            
            Although the effects of CRT on clinical and instrumental indices have been widely 
described at follow-up, we found no descriptions of the evolution of dyssynchrony status at long-
term   follow-up.                                                                
            Aim of our work was then to describe intra-ventricular dyssynchrony in two separate 
groups of ischemic and nonischemic patients scheduled for implantation of a biventricular 
pacemaker and to compare them with a group of control subjects. Moreover, we sought to assess 
the dyssynchrony status for the two groups of patients at 6 and 12 months after implantation.     
Methods
Patients
            Forty consecutive patients implanted in our hospital with a CRT or CRT-Defibrillator 
device (device models 8042, 7277, 7279, Medtronic, Minneapolis, MN, USA) from May 2005 to 
May 2006 were included in the present study. Patients were selected according to current 
guidelines for the CRT: 1) severe HF (New York Heart Association (NYHA) class III or IV), 2) 
depressed LV ejection fraction (LVEF) (≤35%), 3) QRS showing a left bundle branch block 
configuration with a duration ≥120 ms, 4) patient in normal sinus rhythm,  5) optimized medical 
therapy13. Patients with a recent myocardial infarction  or coronary revascularization  (<3 
months), or scheduled revascularization were excluded. The assignment to ischemic etiology 
was based on clinical history of prior myocardial infarction, prior percutaneous coronary 
intervention, or prior coronary bypass surgery, similar to the assignment used in large CRT 
trials1-4.
            Furthermore, we selected a control group of 11 age- and sex-matched healthy subjects 
referred to the echocardiographic laboratory for the evaluation of a cardiac murmur, with normal 
echocardiogram, normal LV function and no history of cardiovascular disease. The study was 
approved by the institutional review board.                                                                               
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Study   procedures                                                                          
            Before implant a complete clinical evaluation of patients was performed to confirm the 
indication   to   CRT.   Afterwards,   echocardiographic   analysis   was   performed   as   detailed 
hereinafter. All patients then underwent a CRT system implant. The transvenous LV lead was 
positioned in a tributary of the coronary sinus to pace the lateral or posterolateral LV wall. After 
a successful implant, echocardiography was used to optimize the atrio-ventricular delay in order 
to maximize LV filling time14. Inter-ventricular pacing interval was set to default value (V-V=0 
ms)   and   remained   unmodified   during   the   study.                                                
            Patients underwent clinical and echocardiographic evaluation at 6 and at 12 months after 
implant for the assessment of response to CRT and of LV intra-ventricular dyssynchrony. In the 
study, the same operator performed all echo assessments and was blinded to the clinical 
evaluation. Similarly, the same cardiologist performed clinical assessment at baseline and 
follow-up   visits   and   was   blinded   to   the   echocardiographic   results.
            Positive response to CRT was defined as a reduction of the LVESV ≥10% with respect to 
the   value   at   baseline15.                                                                      
Echocardiographic   protocol                                                                
            The echocardiographic examination was performed for all patients and for the control 
group in the left lateral decubitus position using commercially available imaging system Sequoia 
C512   (Siemens   AG,   Munich,   Germany).   Each   measurement   was   averaged   over   three 
consecutive beats during sinus rhythm. LV end diastolic and end systolic volumes (LVEDV, 
LVESV) were estimated using the Simpson biplane equation in the apical 4- and 2-chamber 
views16.
            Using color-Doppler in the apical 4-chamber view, the severity of mitral regurgitation 
was evaluated by measurement of the ratio of the maximum mitral regurgitation jet area by 
color-Doppler to the area of the left atrium. A mitral regurgitation area/left atrium area ratio 
≤20%, 20-40% and >40% were classified as mild or grade 1, moderate or grade 2, severe or 
grade 3, respectively17.                                                                                                 
            The LV filling time was measured as the time from the beginning to the end of diastolic 
mitral flow. The inter-ventricular  mechanical delay (IVMD) was calculated  as the time 
difference between the onset of the QRS and the opening of the aortic and pulmonary valves.
            The 95% limits of agreement for intra-observer variability of LVESV measurements 
were (-18 ml to 15 ml).                                                                                                       
Intra-ventricular  dyssynchrony assessment                                                               
            Tissue Doppler Imaging (TDI) pulsed wave velocity was assessed for 3 apical views (4-
chamber, 2-chamber, and long axis). The sample volume was placed in the middle of the basal 
segments of the 6 LV walls (namely the infero-septal, antero-septal, anterior, lateral, posterior, 
and inferior walls). The signal-to-noise ratio was then optimized, the Nyquist limit ranged 
between 10 and 30 cm/s and sweep speed was set at 100 mm/s. Time to onset of systolic velocity 
was measured for all segments from the onset of the QRS complex to the onset of the positive 
component of the regional systolic velocity, and a 6-basal segmental model of LV activation was 
obtained18. The average value from 3 consecutive beats was used in the analysis. Two indices of 
intra-LV dyssynchrony were used in this analysis: 1) the time difference between the longest and 
the shortest interval among the 6 LV walls (Max Delay), and 2) the standard deviation of the 6 
intervals (Ts-SD)11,19-21.                                                                                           
            The 95% limits of agreement for intra-observer variability of the time to onset of systolic 
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velocity measurements were (-11 ms to 13 ms).                                                                             
Statistical   analysis                                                                    
            Continuous data were expressed as means ± standard deviation. Categorical data were 
expressed by percentages. Differences between mean data were compared by a t-test for 
Gaussian variables, and by Mann-Whitney or Wilcoxon non-parametric test for non-Gaussian 
variables, respectively for independent or paired samples. The Bonferroni correction was applied 
for multiple comparisons. Differences in proportions were compared by a Chi-square analysis. A 
p-value <0.05 was considered significant for all tests. All statistical analyses were performed 
using SPSS software (SPSS for Windows, version 12.0, SPSS Inc., Chicago, IL, USA).               
Results
Study   population                                                                              
            Forty consecutive patients were enrolled in the study. Five of these (3 with ischemic and 
2 with nonischemic cardiomyopathy) died before reaching the 6 months term and were excluded 
from the analysis. The baseline characteristics of the remaining 35 patients are reported in Table 
1.
            Patients were divided into two groups according to the etiology of the disease. The two 
groups   did   not   show   any   significant   differences   at   baseline,   in   terms   of   clinical   or 
echocardiographic parameters. Only IVMD showed a trend towards greater values in the 
nonischemic   group.                                                                        
               Furthermore, no differences were noticed in LV lead position that was lateral or 
posterolateral LV wall in all patients. During follow-up the pharmacological therapy remained 
stable in the study population.
Table 1. Baseline characteristics
CRT   response   assessment                                                                                
            At 6 months from implant NYHA functional class, QRS duration and echocardiographic 
parameters indices of response showed improvement in the whole population and in the 2 groups 
(Table 2). The IVMD also decreased significantly. Improvement was confirmed at 12 months.
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            Overall proportion of responders to the therapy (patients showing a reduction of the 
LVESV ≥10%) was 28/35 (80%) at 6 months. Considering in the nonresponder group 5 patients 
who died during the follow-up, the overall response rate was 28/40 (70%). In the ischemic 
group, 13/18 (72%) patients responded to CRT at 6 months, but at 12 months the proportion 
decreased to 12/18 (67%). On the contrary, 15/17 (88%) nonischemic patients (p=0.402 vs. 
ischemic patients) responded to CRT at 6 months, and 16/17 (94%) (p=0.088 vs. ischemic 
patients) at 12 months.
Table 2. Response to CRT 
* p<0.05 Vs Baseline (with Bonferroni correction)
Intra-ventricular   dyssynchrony   assessment                                                          
               Table 3  shows that Max Delay and Ts-SD at baseline were significantly different 
between the two groups of patients and the control group, while no differences were recorded 
between the groups of ischemic and nonischemic patients.
Table 3. Dyssynchrony status for ischemic and nonischemic patients
* p<0.05 Vs Control; † p<0.05 Vs Baseline (with Bonferroni correction)
            The indices did not show any significant variations 6 months after implant in the group of 
nonischemic patients, while they decreased in the group of ischemic patients. Indices remained 
significantly   higher   than   those  of   the  control  group.                                                
            At baseline, the first LV wall to be mechanically activated was most frequently the 
anterior septum: in 6/18 ischemic patients and in 6/17 nonischemic patients. For the majority of 
ischemic patients (6/18) the last activated LV segment was the posterior wall, while for 
nonischemic patients was the lateral wall (in 9/17 patients).                                           
            Table 4 reports the average time to activation of the 6 LV segments. Ischemic patients 
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showed lower average time to activation for lateral and posterior free walls with respect to 
nonischemic   and   higher   values   for   anterior   septum.                                                
            The comparison of dyssynchrony reduction, as measured by the relative decrease of Max 
Delay and Ts-SD, between patients showing maximum time to activation in lateral or posterior 
segments with respect to the others, did not result in any significant differences, neither for the 
whole population nor for ischemic and nonischemic groups. All modifications persisted at 12 
months term after implant.
Table 4. Average time to activation of the 6 LV segments.
* p<0.05 Vs No-Isc (Isc: ischemic)
Association between dyssynchrony and response to CRT                                                         
               In order to seek for any associations between the response to the therapy and the 
dyssynchrony status, we compared baseline values of dyssynchrony indices and their changes at 
follow-up   in   the   two   groups   of   responder   and   nonresponder   patients.
            Average baseline Max Delay for responders and nonresponders was 95±63 ms and 98±91 
ms, while Ts-SD was 38±28 ms and 40±34 ms. Max Delay average variation at 6 months was 
29±79 ms in the group of responders and 55±87 ms in the group of nonresponders, while for Ts-
SD we found an average difference of 11±34 ms in the responders group and of 23±33 ms in the 
nonresponders   group.   However,   none   of   these  differences   was   found   to   be  statistically 
significant.
Discussion
            Present analysis was aimed to provide a description of mechanical dyssynchrony in a 
population of patients candidates to CRT and stratified by etiology, both before implant and at 6 
and   12   months   after   implant.                                                                      
CRT   response                                                                  
               The overall study population showed marked LV dyssynchrony at baseline and 
manifested a substantial clinical and instrumental improvement after 6 months of CRT, in 
accordance with previous experiences. The majority of patients demonstrated a significant 
reduction in ventricular volumes and specifically a decrease of LVESV ≥10% that was shown to 
be a strong predictor of lower long-term mortality and HF events15. Improvement remained 
stable at 12-month follow-up, confirming more recent findings5.                                             
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            Both ischemic and nonischemic patients improved their LV function, although a trend 
was seen towards a lower proportion of patients showing LV reverse remodeling in the ischemic 
group, in accordance with the Miracle Study results5.                                                                 
LV   dyssynchrony                                                                          
            The two indices of LV dyssynchrony used in this analysis presented clearly abnormal 
values in HF patients with respect to those of the control group. Moreover, no significant 
differences were found in global mechanical dyssynchrony between ischemic and nonischemic 
patients, as previously reported by Van de Veire et al.12.                                                     
            However, the analysis of the activation sequence of LV segments resulted in significant 
differences. Even if the last activated segment was most frequently the posterior wall in both 
groups at baseline, the average time to activation for this segment and for the lateral wall was 
significantly higher in nonischemic patients. On the contrary, the anterior septum activated later 
in ischemic patients. This suggests that, despite similar global dyssynchrony indices, patients 
with HF suitable for CRT may present with a different location of mechanical dyssynchrony, 
which primarily seems to be related to the underlying etiology.                                   
            At 6-month follow-up evaluation, both groups presented a reduction in Max Delay and 
Ts-SD values that was found to be statistically significant only in ischemic patients, may be due 
to the limited sample size. Nonetheless, CRT did not yield to a complete normalization of LV 
synchronism.
               Moreover, we were not able to find any association between the improvement of 
dyssynchrony status and baseline location of the most delayed segment. This suggests that a 
successful resynchronization could not only depend on positioning the lead onto the most 
delayed   wall.                                                                                    
            The modifications observed in all measures of dyssynchrony at 6-month persisted at 12-
month follow-up, demonstrating the enduring beneficial effects of CRT in reducing ventricular 
dyssynchrony.
Main   findings                                                                                    
            In this study we confirmed the capability of indices of LV dyssynchrony such as Max 
Delay and Ts-SD, in highlighting the LV mechanical activation dysfunction that characterizes 
CRT candidates with respect to subjects with preserved LV function. However, they were not 
able to describe the differences in LV activation sequence characterizing the two groups, and 
they   seemed   to   fail   in   identifying   patients   that   most   likely   benefit   from   the   therapy.
            These findings seem to confirm recent evidences demonstrating that echocardiographic 
markers of LV dyssynchrony are not suitable for improving patient selection for CRT9,10. The 
lack of predictive power was mainly ascribed to the low reproducibility of the proposed 
echocardiographic indices, specifically for complex TDI-derived measures. Similarly, our results 
confirm that TDI measures lack sensitivity and specificity to affect clinical decisions. Therefore 
these measures should not be used to preclude CRT to patients fulfilling current guidelines for 
implantation.
            To our knowledge, this is the first description of the dyssynchrony status of patients 
treated with CRT at long term follow-up: at 6 months from implant we observed a significant 
modification   of   LV   activation   pattern   which   was   confirmed   at   12   months.
               We also find out that the effectiveness of resynchronization, that is, reduction in 
dyssynchrony indices, is not necessarily related to positive response to the therapy in terms of 
LV   reverse   remodeling.                                                                                    
            Late recurrent LV dilation that was reported in patients with ischemic HF was ascribed to 
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the deterioration in LV function, possibly associated to the progressive regional loss of viable 
myocardium that is known to occur in ischemic heart disease, rather than the loss of efficacy of 
resynchronization5. Along this line, our findings seem to demonstrate the persistence of effective 
resynchronization at 6 and 12 months after implant.                                                       
            These findings confirm that the management of the CRT patient during follow-up should 
require the careful assessment of several different clinical and instrumental parameters rather 
than being based only on repetitive assessment of resynchronization efficacy.                    
Study   limitations                                                                                  
            The present results should be interpreted within the constraints of the study limitations. 
This study was performed in a small patient population. Moreover, our TDI assessment protocol 
included the basal segment only. The observation of mid-apical segments could provide 
additional information. In our study we assessed LV dyssynchrony by means of pulsed wave 
TDI indices of activation delay and dispersion. Requiring multiple acquisitions, the data 
collection with pulsed wave TDI may be influenced by beat-to-beat variability. However, also 
several methods with color TDI require multiple acquisitions because segments of interest lie in 
three different view planes. In color TDI method, the time to peak of systolic velocity is usually 
estimated, while in pulsed TDI both time to peak and to onset have been described. Recently, it 
was shown that the feasibility and the accuracy of the time to onset estimation were higher with 
respect to time to peak20. Similarly, in our series we obtained acceptably low intra-observer 
variability.
            Finally, we did not provide any data about the relation between the site of LV pacing and 
the resulting  activation  pattern.                                                                                
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